Next Article in Journal
Fibroblasts Collagen Production and Histological Alterations in Hereditary Gingival Fibromatosis
Previous Article in Journal
Gene Therapy Today and Tomorrow
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessCase Report

A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan

1
Department of Internal Medicine/Hospitalist, SOVAH Health, Martinsville, VA 24112, USA
2
Department of Clinical Pharmacology, Seth G.S. Medical College & King Edward Memorial Hospital, Mumbai 400012, India
3
Department of Medicine/Nephrology, SOVAH Health, Martinsville, VA 24112, USA
4
Division of Infectious Diseases, University of Louisville, Louisville, KY 40202, USA
5
Department of Neurology, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA
*
Author to whom correspondence should be addressed.
Diseases 2019, 7(2), 38; https://doi.org/10.3390/diseases7020038
Received: 17 April 2019 / Revised: 12 May 2019 / Accepted: 13 May 2019 / Published: 14 May 2019
  |  
PDF [181 KB, uploaded 14 May 2019]

Abstract

Rhabdomyolysis is caused by extensive damage to skeletal muscles resulting in elevated creatine phosphokinase (CPK), Lactate dehydrogenase (LDH), and aspartate aminotransferase (AST), leading to life-threatening consequences like acute renal failure, cardiac arrhythmias, and hyperthermia. A variety of causes for muscle damage are known, and one of the most common is drug-induced. Statins and many other agents are known to induce muscle damage, but here we report Entresto™ (Sacubitril/Valsartan) induced rhabdomyolysis which has not been previously reported as solely responsible in the literature. View Full-Text
Keywords: rhabdomyolysis; entresto; sacubitril/valsartan; adverse drug reaction rhabdomyolysis; entresto; sacubitril/valsartan; adverse drug reaction
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Rawla, P.; Raj, J.P.; George, S.M.; Nathala, P.; Vellipuram, A.R. A Rare Adverse Event of Rhabdomyolysis Caused by Sacubitril/Valsartan. Diseases 2019, 7, 38.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top